Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd. clinical trials

A subsidiary of Sinopharm

The registry lists 1 studies whose lead sponsor is Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 3, 2022.

Status

Status unknown: 1

Phase

Phase 2: 1

Where

United Arab Emirates: 1

Registry sponsor names on this page

Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.1 study

Something wrong with this grouping? Tell us on the Sinopharm page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Sinopharm studies →

Human COVID-19 Immunoglobulin (COVID-HIG) Therapy for COVID-19 PatientsStatus unknownNCT05173441Phase 2
Sponsor listed in the registry: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.